Nektar Therapeutics (NKTR)

56.23 -0.39 (-0.69%) USD  |  NASDAQ  |  Jun 09, 16:00
56.80 +0.57 (+1.01%) After-Hours: 06:46
More

Nektar Therapeutics Total Operating Expenses (Quarterly)

Total Operating Expenses (Quarterly) Chart

View Total Operating Expenses (Quarterly) for NKTR.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Total Operating Expenses (Quarterly) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Total Operating Expenses (Quarterly) Range, Past 5 Years

View Total Operating Expenses (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Total Operating Expenses (Quarterly) Benchmarks

View Total Operating Expenses (Quarterly) Benchmarks
Start Trial
Eli Lilly & Co. Upgrade
Aquestive Therapeutics, Inc. Upgrade
Esperion Therapeutics, Inc. Upgrade
Alumis, Inc. Upgrade
Tvardi Therapeutics, Inc. Upgrade